Anti-TNFRSF4/OX40/CD134 Antibody (Cudarolimab)
Catalog No.
F1122
Anti-TNFRSF4/OX40/CD134 Antibody (Cudarolimab)
Featured Products
Cudarolimab (IBI101) is a fully human anti-OX40 (CD134, a co-stimulatory molecule expressed by activated immune cells) antibody. Cudarolimab inhibits the binding of OX40 to its ligand OX40L. Cudarolimab has anti-tumor activity and can be used in cancer-related research.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145 kDa
Dry ice
2244739-29-3
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
IBI-101, IBI101
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P43489
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human TNFRSF4 His at 2 ug/mL can bind Anti-TNFRSF4/OX40/CD134 Antibody (Cudarolimab)
TNFRSF4 / OX40 / CD134
Please avoid freeze-thaw cycles.